Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Long-COVID symptoms can last more than a year and change over time.

PCOS is linked to low-grade chronic inflammation.

Neuroendocrine paraneoplastic syndromes often show skin changes, helping early diagnosis and requiring a team approach for best care.

Treating cystoid macular oedema in uveitis is difficult and risky.

Nail changes are common in alopecia areata and can indicate its severity.

A woman with hair loss regrew white hair after taking prednisolone.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

The dog's skin condition improved quickly with treatment and did not return.

Low-dose oral minoxidil is safe for alopecia patients, even those prone to edema.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Symptom experience doesn't affect medication compliance in liver transplant patients.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

People with mycosis fungoides/Sézary syndrome have a much lower quality of life.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Corticosteroids improved symptoms in a man with Cronkhite-Canada Syndrome.